Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzoin resin is a natural balsamic resin obtained from the bark of several species of trees in the genus *Styrax*, primarily *Styrax benzoin* and *Styrax tonkinensis*. It is produced as a pathologic exudate in response to bark injury. The resin is chemically complex, containing balsamic acid esters (such as benzyl benzoate), benzoic acid, cinnamic acid, and various triterpenoids. Historically used as incense and a flavoring agent, it has significant therapeutic applications as a topical antiseptic and protectant. It is commonly formulated as Compound Benzoin Tincture to treat minor skin irritations, wounds, and ulcers. Additionally, its fumes are used traditionally for respiratory relief and in religious ceremonies. Modern research has identified its potential as an antibacterial, antifungal, and antioxidant agent, with specific inhibitory activities against enzymes like alpha-glucosidase and bacterial targets such as dihydrofolate reductase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzoin resin.